Bispecific Antibodies Signal A New Era For Autoimmune Disease Treatment
A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the role of B cells and self-reactive antibodies in lupus, systemic sclerosis, and rheumatoid arthritis.
(Forbes, 2025-11-04T16:46:29Z)